Krystal Biotech, Inc. (KRYS)

Krystal Biotech Revenue

In the year 2025, Krystal Biotech had annual revenue of $389.13M with 33.94% growth. Krystal Biotech had revenue of $107.11M in the quarter ending December 31, 2025, with 17.52% growth.

• Revenue (ttm): $389.13M
• Revenue Growth: +33.94%
• P/S Ratio: 20.92
• Revenue / Employee: $1,319,085
• Employees: 295
• Market Cap: 8.14B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	389.13M	98.62M	33.94%
Dec 31, 2024	290.52M	239.82M	473.02%
Dec 31, 2023	50.70M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-